Drugs Controller General of India Current Affairs, GK & News
India: Expert panel recommends approval to Sputnik V vaccine
An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI) is to take a final call on the recommendation. When approved, Sputnik will be the third COVID-19 vaccine to be available in India. Sputnik V Vaccine The ..
Month: Current Affairs - April, 2021
Category: Economy & Banking Current Affairs
Topics: COVAXIN • Covishield • Drugs Controller General of India • Emergency Use Authorisation • Russian Direct Investment Fund • SPUTNIK V
DCGI approves Favipiravir for treating COVID-19
The drugs controller general of India (DGCI) granted approval to Glenmark Pharmaceuticals to manufacture and market oral antiviral drug Favipiravir to treat mild and moderate COVID-19 cases in India. The drug will be marketed under the brand name ‘FabiFlu’. It is known to prevent the virus from replication. In Japan, the drug is sold under ..
Month: Current Affairs - June, 2020
Topics: Coronavirus • Drugs Controller General of India • Health
Clinical trial begins of plant based drug for Covid-19
On 5th June, 2020, the Drugs Controller General of India allowed Sun Pharmaceutical to conduct trial for the first phytopharmaceutical or plant based drug AQCH to treat covid-19 patients. The trial has begun by Sun pharmaceutical in collaboration with ICGEB New Delhi and CSIR IIIM Jammu with support by CSIR and DBT. Mumbai based Sun ..
Topics: ACQH • COVID-19 • CSIR • Drugs Controller General of India
DCGI allows Indian firm to conduct phase 1 trials for Zika vaccine
The Drugs Controller General of India (DCGI) has granted permission to Indian firm to conduct Phase-I clinical trials for a Zika vaccine. It was announced by Union Minister of State (MoS) for Health and Family Welfare Ashwini Kumar Choubey in Lok Sabha. Zika Virus Zika Virus is vector borne diseases spread by Aedes egypti mosquito. ..
Month: Current Affairs - December, 2017
Topics: Clinical trials • DCGI • Drugs Controller General of India • Pharmaceutical Sector • Science and Technology • Zika vaccine